A therapeutics platform for curing inflammatory disorders
Company research
Public company, workplace, funding, and market signals
Overview
Boston-based biotech founded in spring 2021 that is developing non-immunosuppressive, oral, bacterial-molecule-inspired therapies to restore immune balance and treat inflammatory diseases, starting with Crohn’s disease.
Primary product
An oral, bowel-specific small-molecule immunomodulatory therapy for Crohn’s disease and other inflammatory diseases
Founded
2021
Headquarters
Boston, Massachusetts, United States; Pagliuca Harvard Life Lab, 127 Western Avenue, Allston, MA 02134-1008
Team size
1-10
Industry
Biotechnology Research
Sub-industry
Inflammatory disease therapeutics
Offices
Pagliuca Harvard Life Lab, 127 Western Avenue, Allston, MA 02134-1008, Allston, MA, United States
Open Positions
0 jobs at Promakhos Therapeutics
No open positions
Check back later for new openings